PARP inhibitor niraparib as a radiosensitizer promotes antitumor immunity of radiotherapy in EGFR-mutated non-small cell lung cancerN. Zhang, Conghua Xie, Yanyan Luo et al.|Clinical & Translational Oncology|2021Cited by 32
Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID‐19 patients: Multicenter retrospective studyZihang Zeng, Yan Chen, Xin Liao et al.|Journal of Medical Virology|2020Cited by 30